Search Results - "Wanionek, Kimberli A."

Heterotypic Dengue Infection with Live Attenuated Monotypic Dengue Virus Vaccines: Implications for Vaccination of Populations in Areas Where Dengue Is Endemic by Durbin, Anna P., Schmidt, Alexander, Elwood, Dan, Wanionek, Kimberli A., Lovchik, Janece, Thumar, Bhavin, Murphy, Brian R., Whitehead, Stephen S.

“…Background. Because infection with any of the 4 Dengue virus serotypes may elicit both protective neutralizing antibodies and nonneutralizing antibodies…”
Get full text

Phase I Clinical Evaluation of rDEN4Δ30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity by McArthur, Julie H., Durbin, Anna P., Marron, Jennifer A., Wanionek, Kimberli A., Thumar, Bhavin, Pierro, Dennis J., Schmidt, Alexander C., Blaney, Joseph E., Murphy, Brian R., Whitehead, Stephen S.

“…The rDEN4Δ30-200,201 is a live attenuated DENV-4 vaccine candidate specifically designed to further attenuate the rDEN4Δ30 parent virus. In the present study,…”
Get full text

Phase I Clinical Evaluation of rDEN4 Delta 30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity by McArthur, J H, Durbin, A P, Marron, JA, Wanionek, KA, Thumar, B, Pierro, D J, Schmidt, A C, Blaney, JE Jr, Murphy, B R, Whitehead, S S

“…The rDEN4 Delta A30-200,201 is a live attenuated DENV-4 vaccine candidate specifically designed to further attenuate the rDEN4 Delta 30 parent virus. In the…”
Get full text

Phase I Clinical Evaluation of rDEN4A30-200,201 : A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity by MCARTHUR, Julie H, DURBIN, Anna P, MARRON, Jennifer A, WANIONEK, Kimberli A, THUMAR, Bhavin, PIERRO, Dennis J, SCHMIDT, Alexander C, BLANEY, Joseph E, MURPHY, Brian R, WHITEHEAD, Stephen S

Get full text

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity by McArthur, Julie H, Durbin, Anna P, Marron, Jennifer A, Wanionek, Kimberli A, Thumar, Bhavin, Pierro, Dennis J, Schmidt, Alexander C, Blaney, Jr, Joseph E, Murphy, Brian R, Whitehead, Stephen S

“…The rDEN4Delta30-200,201 is a live attenuated DENV-4 vaccine candidate specifically designed to further attenuate the rDEN4Delta30 parent virus. In the present…”
Get full text

Phase I Clinical Evaluation of rDEN4{Delta}30-200,201: A Live Attenuated Dengue 4 Vaccine Candidate Designed for Decreased Hepatotoxicity by McArthur, Julie H, Durbin, Anna P, Marron, Jennifer A, Wanionek, Kimberli A, Thumar, Bhavin, Pierro, Dennis J, Schmidt, Alexander C, Blaney, Joseph E., Jr, Murphy, Brian R, Whitehead, Stephen S

Get full text